Drug Crisis: What is the Massachusetts State Doing to Control the Epidemic?

Pre-Conditions for the Growth of Addiction

The United States continues to grapple with a severe drug addiction crisis, particularly involving opioids and, increasingly, marijuana. Since 2000, opioid-related deaths have nearly quintupled, with Massachusetts experiencing one of the nation’s most pronounced surges—more than double the national average. The crisis was exacerbated by the pharmaceutical industry’s aggressive marketing of prescription opioids, a surge in illicit fentanyl, and broader societal factors such as economic distress and mental health challenges. Highly potent synthetic opioids like fentanyl have become ubiquitous in the drug supply, amplifying overdose risk. Legal and cultural shifts around marijuana have also increased its availability, though associated mortality remains significantly lower compared to opioids.

The rapid spread of addiction can be traced to multiple factors: over-prescription of painkillers in the 1990s and early 2000s, the subsequent transition to heroin and fentanyl as prescription opioids became harder to obtain, and the contamination of street drugs with deadly synthetic compounds. In Massachusetts, the crisis was particularly acute due to regional drug trafficking patterns and a high prevalence of fentanyl in the local narcotics supply. These dynamics have made addiction both more common and more lethal, especially in vulnerable populations.

Social and Economic Impacts

Drug addiction, and the opioid crisis in particular, has had profound effects on public health, safety, and economic productivity in Massachusetts and across the nation. Emergency departments are overwhelmed by overdose cases, treatment facilities face capacity challenges, and chronic illnesses related to substance use have surged. The financial burden on the healthcare system is immense, with costs stemming from emergency interventions, long-term care, and lost productivity due to disability or premature death. Public safety agencies, from police to emergency medical services (EMS), have seen their workloads increase dramatically as they respond to overdose calls and related crimes.

Economically, the crisis has led to lost workforce participation, reduced earnings, and higher public spending on healthcare, law enforcement, and social services. Substance use disorders also contribute to family breakdowns, homelessness, and a cycle of intergenerational poverty. The impact is not distributed evenly: racial and gender disparities persist, with Black, non-Hispanic residents—especially men—experiencing the fastest-growing rates of opioid-related deaths in recent years. These social and economic repercussions underscore the urgency of a coordinated, data-driven public health response.

Federal Countermeasures

1. Expansion of Medication-Assisted Treatment (MAT) in CorrectionsFederal initiatives now prioritize providing medications for opioid use disorder (MOUD), including buprenorphine, methadone, and naltrexone, to incarcerated individuals. This approach, tested in Massachusetts jails, has shown that inmates who receive MOUD are far more likely to engage in treatment upon release, continue treatment, and avoid reincarceration or overdose. Such programs are being scaled nationally to interrupt the cycle of addiction and incarceration.
2. National Drug Overdose Surveillance and Rapid ResponseThe Centers for Disease Control and Prevention (CDC) has enhanced real-time drug overdose surveillance through the National Vital Statistics System. By providing provisional, up-to-date mortality data, public health officials can identify emerging hotspots and trends, enabling faster, targeted interventions and resource allocation.
3. Prescription Drug Monitoring Programs (PDMPs)All states, including Massachusetts, now operate PDMPs to track prescriptions of controlled substances. These databases help identify potential misuse, “doctor shopping,” and inappropriate prescribing patterns, allowing for earlier intervention and reduced overprescription of opioids.
4. Increased Access to NaloxoneThe federal government has expanded access to naloxone, a life-saving opioid overdose reversal medication, through funding for distribution to first responders, community organizations, and individuals at risk. This has contributed to a measurable reduction in fatal overdoses in many regions, including Boston, where opioid-related deaths have recently declined.
5. Public Health Campaigns and Harm Reduction ServicesNationally, there is a push to fund harm reduction services such as needle exchanges, supervised consumption sites, and public education campaigns. These efforts aim to reduce infectious disease transmission, connect users to treatment, and destigmatize substance use disorder, making recovery more accessible.

Federal Initiatives to Combat the Drug Crisis

Initiative	Target Population	Impact
MAT Expansion in Jails	Incarcerated individuals with OUD	Reduces overdose, recidivism, and increases treatment engagement
CDC Overdose Surveillance	General public, public health agencies	Enables rapid response to outbreaks, data-driven policy
Prescription Drug Monitoring	Healthcare providers, pharmacists, patients	Curbs overprescribing and identifies misuse early
Naloxone Access Expansion	First responders, at-risk individuals	Prevents fatal overdoses, supports harm reduction
Harm Reduction Services	Active drug users, communities	Reduces disease, connects to care, destigmatizes SUD

Massachusetts Case – The Numbers Speak for Themselves

Massachusetts has been one of the states hardest hit by the opioid crisis. The opioid-related death rate in the state is more than double the national average, with fentanyl now involved in the vast majority of fatalities—84.3% of overdose deaths from 2020 to 2023 involved fentanyl. According to reports on the massachusetts drug problem, preliminary data for 2022 indicated another increase in overdose deaths, with Black, non-Hispanic residents seeing the largest surge—up 41% for men and 47% for women compared to the previous year. These trends highlight both the severity of the crisis and persistent health inequities.

Recent developments, however, offer hope: Boston reported a 38% decrease in opioid-related deaths in 2024 compared to 2023, the lowest number in nine years, with even steeper declines among Black and Latino residents. This progress follows intensive local efforts to address health disparities and expand access to treatment and harm reduction.

State Programs Targeting the Drug Crisis

• Bureau of Substance Addiction Services (BSAS) DashboardThe BSAS Dashboard provides real-time, granular data on substance-related deaths, EMS incidents, and treatment services at the city, county, and state levels. This transparency enables policymakers and service providers to identify emerging trends, allocate resources efficiently, and measure the impact of interventions.
• Prescription Monitoring Program (PMP)Massachusetts’ PMP tracks all prescriptions for controlled substances, allowing providers and regulators to monitor for potential misuse, overprescribing, and “doctor shopping.” The system facilitates early intervention and supports safer prescribing practices across the state.
• Drug Checking and Harm Reduction InitiativesIn collaboration with Brandeis University, Massachusetts operates a drug checking program that tests substances in the illicit drug supply for contaminants like fentanyl and xylazine. This information is shared with public health agencies and the public to inform harm reduction strategies and prevent overdose.

Approaches in Neighboring Regions

• New HampshireNew Hampshire, like Massachusetts, faces one of the highest fentanyl-related death rates in the nation. The state has prioritized expanding access to MAT, particularly in rural areas, and has launched a “Safe Station” program, allowing individuals to seek help at fire stations for immediate referral to treatment. New Hampshire also invests heavily in public awareness campaigns to reduce stigma and encourage early intervention.
• Rhode IslandRhode Island has been a national leader in implementing medication-assisted treatment (MAT) within its correctional system, ensuring continuity of care for incarcerated individuals with opioid use disorder. The state has also developed a robust network of harm reduction services, including syringe exchange programs and overdose prevention sites, to reduce fatalities and connect users to care.
• ConnecticutConnecticut has focused on strengthening its Prescription Drug Monitoring Program and increasing the availability of naloxone to first responders and community organizations. The state has also implemented cross-agency task forces to address the opioid crisis through coordinated public health and public safety strategies.

Is It Possible to Stop the Crisis? Looking to the Future

Approaches With Proven Potential

• Investment in Treatment and Recovery ServicesExpanding access to evidence-based treatments like MAT, counseling, and peer support has shown to reduce mortality and improve long-term outcomes. Programs that begin treatment in correctional settings and ensure continuity of care post-release are particularly effective.
• Early Intervention and PreventionTargeted education, screening, and early intervention for at-risk populations—especially youth and those with mental health disorders—can prevent substance use disorders from developing or worsening.
• Interagency Cooperation and Data IntegrationCoordinated efforts across healthcare, law enforcement, social services, and education, supported by real-time data-sharing platforms, enable more effective, targeted responses to the crisis.
• Educational CampaignsPublic awareness campaigns that destigmatize addiction and promote harm reduction empower communities to seek help and support those in recovery.
• Decriminalization and Diversion ProgramsShifting from punitive approaches to public health models—such as drug courts and diversion to treatment—reduces incarceration rates and improves health outcomes for people with substance use disorders.

Approaches With Limited Effectiveness

• Isolation Without SupportSimply incarcerating individuals with substance use disorders without access to treatment or recovery support fails to address the root causes of addiction and often leads to relapse and reincarceration.
• Repressive Measures AloneOver-reliance on law enforcement to combat drug use, without complementary public health strategies, has not reduced addiction rates or overdose mortality in the long term.
• Lack of AftercareFailing to provide ongoing support after detox or short-term treatment results in high rates of relapse. Sustained recovery requires comprehensive, long-term care and community integration.

Conclusions and Recommendations

The drug crisis in Massachusetts and the United States is a complex, evolving challenge that demands a multifaceted, evidence-based response. While recent data from Boston and other regions show promising declines in overdose deaths, disparities persist, and the threat of potent synthetic drugs remains high. Massachusetts has demonstrated that progress is possible through data transparency, harm reduction, expanded treatment access, and interagency cooperation—but sustained investment and political will are essential.

Public health responsibility requires not only effective policies but also open dialogue, destigmatization of addiction, and long-term support for individuals and families affected by substance use disorder. Each state must tailor its approach to local conditions, but the most successful strategies will be those rooted in reliable data, innovation, and a commitment to health equity. The fight against the drug crisis is far from over, but with continued collaboration and compassion, a healthier future is within reach.